Breast carcinoma and aromatase inhibitors (ai) - theory and practice
- At: 2010 FIP Congress in Lisbon (Portugal)
- Type: Poster
- By: STRBAC, Ivana (Pharmacy Novi Sad, Novi Sad, Yugoslavia)
- Co-author(s): Salma, Svetlana (Institut of Oncology Vojvodina, NOVI SAD, Serbia)
Strbac, Zoran (Emergency Medical Service Novi Sad, NOVI SAD, Serbia)
Introduction:Aromatase inhibitors (exemestane, letrozole, anastrazole) are introduced into the hormonal therapy of breast carcinoma.Pharmacists help patients who use AI, inform them about possible side effects and offer advice how to overcome them.
Aim:The aim of the study is to show the frequency with which these medicaments are delivered in our .. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.